192 related articles for article (PubMed ID: 29094048)
21. High levels of Schistosoma mansoni infections among schoolchildren in central Sudan one year after treatment with praziquantel.
Ahmed AM; El Tash LA; Mohamed EY; Adam I
J Helminthol; 2012 Jun; 86(2):228-32. PubMed ID: 21729382
[TBL] [Abstract][Full Text] [Related]
22. Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy.
Bustinduy AL; Waterhouse D; de Sousa-Figueiredo JC; Roberts SA; Atuhaire A; Van Dam GJ; Corstjens PL; Scott JT; Stanton MC; Kabatereine NB; Ward S; Hope WW; Stothard JR
mBio; 2016 Aug; 7(4):. PubMed ID: 27507822
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of Praziquantel Treatment and
Berhanu MS; Atnafie SA; Ali TE; Chekol AA; Kebede HB
Ethiop J Health Sci; 2022 May; 32(3):631-640. PubMed ID: 35813666
[TBL] [Abstract][Full Text] [Related]
24. A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg/kg vs. 60 mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil.
Olliaro PL; Vaillant MT; Belizario VJ; Lwambo NJ; Ouldabdallahi M; Pieri OS; Amarillo ML; Kaatano GM; Diaw M; Domingues AC; Favre TC; Lapujade O; Alves F; Chitsulo L
PLoS Negl Trop Dis; 2011 Jun; 5(6):e1165. PubMed ID: 21695161
[TBL] [Abstract][Full Text] [Related]
25. Increasing teacher motivation and supervision is an important but not sufficient strategy for improving praziquantel uptake in Schistosoma mansoni control programs: serial cross sectional surveys in Uganda.
Muhumuza S; Katahoire A; Nuwaha F; Olsen A
BMC Infect Dis; 2013 Dec; 13():590. PubMed ID: 24330594
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme.
Gower CM; Gehre F; Marques SR; Lamberton PHL; Lwambo NJ; Webster JP
Parasit Vectors; 2017 Dec; 10(1):593. PubMed ID: 29197426
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of single dose albendazole and praziquantel drugs among helminth-infected school children at Rural Bahir Dar, northwest Ethiopia.
Hailu T; Abera B; Mulu W; Alemu M; Yizengaw E; Genanew A
Trop Doct; 2018 Oct; 48(4):270-272. PubMed ID: 30001683
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and side effects of praziquantel in the treatment of Schistosomiasis mansoni in schoolchildren in Shesha Kekele Elementary School, Wondo Genet, Southern Ethiopia.
Erko B; Degarege A; Tadesse K; Mathiwos A; Legesse M
Asian Pac J Trop Biomed; 2012 Mar; 2(3):235-9. PubMed ID: 23569905
[TBL] [Abstract][Full Text] [Related]
29. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
Dabo A; Doucoure B; Koita O; Diallo M; Kouriba B; Klinkert MQ; Doumbia S; Doumbo O
Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of praziquantel and dihydroartemisinin piperaquine combination for treatment and control of intestinal schistosomiasis: A randomized, non-inferiority clinical trial.
Mnkugwe RH; Minzi O; Kinung'hi S; Kamuhabwa A; Aklillu E
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008619. PubMed ID: 32966290
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the Impact of Different Mass Drug Administration Strategies on Infection with
Olsen A; Kinung'hi S; Magnussen P
Am J Trop Med Hyg; 2018 Dec; 99(6):1573-1579. PubMed ID: 30350779
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection.
Utzinger J; N'Goran EK; N'Dri A; Lengeler C; Tanner M
Trop Med Int Health; 2000 Nov; 5(11):771-8. PubMed ID: 11123824
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium.
Taylor P; Murare HM; Manomano K
J Trop Med Hyg; 1988 Feb; 91(1):13-7. PubMed ID: 3126306
[TBL] [Abstract][Full Text] [Related]
34. Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities and their associated factors.
Mueller A; Fuss A; Ziegler U; Kaatano GM; Mazigo HD
BMC Infect Dis; 2019 Oct; 19(1):832. PubMed ID: 31590657
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
Coulibaly JT; N'gbesso YK; Knopp S; Keiser J; N'Goran EK; Utzinger J
PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
[TBL] [Abstract][Full Text] [Related]
36. Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on Childhood
Shen Y; Wiegand RE; Olsen A; King CH; Kittur N; Binder S; Zhang F; Whalen CC; Secor WE; Montgomery SP; Mwinzi PNM; Magnussen P; Kinung'hi S; Campbell CH; Colley DG
Am J Trop Med Hyg; 2019 Dec; 101(6):1336-1344. PubMed ID: 31407653
[TBL] [Abstract][Full Text] [Related]
37. Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda.
Frenzel K; Grigull L; Odongo-Aginya E; Ndugwa CM; Loroni-Lakwo T; Schweigmann U; Vester U; Spannbrucker N; Doehring E
Am J Trop Med Hyg; 1999 Jun; 60(6):927-31. PubMed ID: 10403322
[TBL] [Abstract][Full Text] [Related]
38. Schistosoma mansoni infection among preschool age children attending Erer Health Center, Ethiopia and the response rate to praziquantel.
Kemal M; Tadesse G; Esmael A; Abay SM; Kebede T
BMC Res Notes; 2019 Apr; 12(1):211. PubMed ID: 30953565
[TBL] [Abstract][Full Text] [Related]
39. Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.
Shen Y; King CH; Binder S; Zhang F; Whalen CC; Evan Secor W; Montgomery SP; Mwinzi PNM; Olsen A; Magnussen P; Kinung'hi S; Phillips AE; Nalá R; Ferro J; Aurelio HO; Fleming F; Garba A; Hamidou A; Fenwick A; Campbell CH; Colley DG
BMC Infect Dis; 2017 Sep; 17(1):652. PubMed ID: 28962552
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of serum-based real-time PCR to detect Schistosoma mansoni infection before and after treatment.
Fuss A; Mazigo HD; Mueller A
Infect Dis Poverty; 2020 Jun; 9(1):74. PubMed ID: 32571433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
